Skip to main content

Investor

By Jessica Hagen | 01:53 pm | November 20, 2024
The funds will be used to enhance its technology, expand its partnership with payers and providers, scale its reach and accelerate clinical research through enrollment support.
By Jessica Hagen | 04:33 pm | November 18, 2024
The women's healthcare company failed to find adequate product market fit, and the company's CEO, Alison Greenberg, says many lessons were learned along the way.
By Jessica Hagen | 12:36 pm | November 18, 2024
The General Catalyst Institute, launched in the U.S. in September, is expanding into India and inviting policymakers and entrepreneurs in the region to collaborate.
By Anthony Vecchione | 02:14 pm | November 12, 2024
Sanofi invests in Zucara Therapeutics and MintNeuro raises $1.27 million in a funding round.
By Jessica Hagen | 06:50 pm | November 11, 2024
According to Bloomberg, the brain-implant chipmaker raised $93 million in funding, increasing the startup's valuation to approximately $500 million.
By Anthony Vecchione | 04:12 pm | November 08, 2024
HATCo will spend a total of $550 million in capital funding to invest in technologies and innovation.
By Jessica Hagen | 02:00 pm | November 08, 2024
The guidance aims to help countries move toward healthcare digitization through a person-centered point of service system.
By Jessica Hagen | 01:04 pm | November 07, 2024
The company also reported Q3 2024 earnings, noting total revenue of $76.4 million, adjusted EBITDA of $7.3 million and a net loss of $14.7 million.
By Jessica Hagen | 03:24 pm | November 06, 2024
The company will use the funds to expand in Asian and U.S. markets, advance its AI algorithms and grow its workforce.
By Jessica Hagen | 03:54 pm | November 05, 2024
The company reported a 77% YOY increase in revenue in Q3 2024 and plans to release a generic version of Novo Nordisk's GLP-1 drug on its platform in 2025.